Red Havas has announced the launch of Red Havas Health, a global micro-network focused on health, in response to increasing demand from clients globally.
The FDA has approved Akebia Therapeutics’ vadadustat as a treatment for anaemia caused by chronic kidney disease (CKD) in dialysis patients, becoming the first rival to GS